Overview

A Study to Evaluate the Drug-drug Interaction and Safety Between "BR6001-1" and "BR6001-2"

Status:
Completed
Trial end date:
2023-05-09
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to evaluate the drug-drug interaction and safety between "BR6001-1" and "BR6001-2" in healthy adult volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd